Acylcarnitines Are Associated with Metabolic Syndrome and Hypertension in Two Contrasted Obese Populations
Nutrients · 01.04.2026 · 18 (7) · 1137
DOI: 10.3390/nu18071137 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Nutrients, online erschienen am 01.04.2026. Verfasst von Nicodème Chabi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Inserm UMR 1256 NGERE (Nutrition-Genetics-Environmental Risks), Université de Lorraine, F-54000 Nancy, France. Hauptthemen laut MEDLINE: Carnitine, Hypertension, Metabolic Syndrome, Obesity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Inserm, SOciété Française et Francophone de Chirurgie de l’Obésité et des Maladies Métaboliques-scholarship, China Scholarship Council.
Abstract (Originalsprache)
Background
Metabolic syndrome (MetS) is a constellation of components that includes type 2 diabetes/hyperglycemia, central obesity, hypertension, and dyslipidemia. Its prevalence is increasing dramatically in Africa, where it is predominant in obese females. Incomplete fatty acid β-oxidation is among the complex mechanisms that increase MetS risk. However, it remains unclear whether MeS components are associated with increased acylcarnitine categories.
Objective
The aim of this study was to analyze the relationship between acylcarnitines and all components of metabolic syndrome in females with obesity from two populations with distinct ethnicities and dietary habits.
Methods
We investigated the association of obesity (BMI > 35) with acylcarnitines determined by LC–MS/MS with MetS components in women from Benin, West Africa, and French women. Acylcarnitines and biological and clinical outcomes of MetS according to International Diabetes Federation (IDF) criteria were assessed in 428 ambulatory women recruited at the market of Dantokpa, Cotonou, and 220 women of Aldepi/Obesepi cohort recruited in the North-East of France.
Results
Compared to those without MetS, we observed an association of short-, medium-, and long-chain acylcarnitines (SC, MC, LC) with MetS (p = 0.0001; p < 0.0001 and p = 0.0004, respectively) in African women and of SC acylcarnitines with MetS (p < 0.0001), blood glucose (p < 0.001), low HDL-cholesterol (p < 0.05) and high triglycerides (p < 0.01) in French women. We also observed significant associations of MC and LC total and mono-unsaturated acylcarnitines with hypertension in both African and French populations (p < 0.001 and p < 0.01, respectively). The independent determinants of systolic blood pressure were age, body mass index, glycemia, long-chain acylcarnitines, LDL-C and HDL-C.
Conclusions
An association of acylcarnitine indexes of altered SC, MC, LC fatty acid β-oxidation with hypertension was reported in the two contrasted women populations, while an association of altered SC fatty acid β-oxidation with glucose and hypertriglyceridemia was reported in French women only. The association of altered acylcarnitine indexes with high SBP could be related to the effects of impaired β-oxidation on endothelial dysfunction. This study was registered at clinical trials.gov as NCT02663388.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Inserm UMR 1256 NGERE (Nutrition-Genetics-Environmental Risks), Université de Lorraine, F-54000 Nancy, France.
- Laboratory of Biochemistry and Molecular Biology, University of Cotonou, Cotonou 04 BP 0320, Benin.
- Inserm UMR 1256 NGERE (Nutrition-Genetics-Environmental Risks), Multidisciplinary Unit of Metabolic and Endocrine Surgery, Department of Gastrointestinal, Metabolic, and Cancer Surgery (CVMC), CHRU-Nancy, University of…
- Inserm UMR 1256 NGERE (Nutrition-Genetics-Environmental Risks), Department of Endocrinology Diabetology and Nutrition, CHRU-Nancy, University of Lorraine, F-54000 Nancy, France.
- Inserm UMR 1256 NGERE (Nutrition-Genetics-Environmental Risks), Reference Medical Biology Laboratory (LBMR), Department of Biochemistry, Molecular Biology and Nutrition, CHRU-Nancy, University of Lorraine, F-54000 Nancy…
- Joan Klein Jacobs Center for Precision Nutrition and Health, Cornell University, Ithaca, NY 14853, USA.
ORCID-Profile: Almut Heinken, Laurent Brunaud, Jean-Louis Gueant, Rosa-Maria Guéant-Rodriguez
Förderung
- Inserm
- SOciété Française et Francophone de Chirurgie de l’Obésité et des Maladies Métaboliques-scholarship
- China Scholarship Council
Zitieren
APA
Chabi, N., Nominé-Criqui, C., Heinken, A., Quilliot, D., Brunaud, L., Li, Z., Jeannesson-Thivisol, E., Sanni, A., Ziegler, O., Gueant, J. L., & Guéant-Rodriguez, R. M. (2026). Acylcarnitines Are Associated with Metabolic Syndrome and Hypertension in Two Contrasted Obese Populations. Nutrients, 18(7), 1137. https://doi.org/10.3390/nu18071137
Vancouver
Chabi N, Nominé-Criqui C, Heinken A, Quilliot D, Brunaud L, Li Z, et al. Acylcarnitines Are Associated with Metabolic Syndrome and Hypertension in Two Contrasted Obese Populations. Nutrients. 2026;18(7):1137. doi:10.3390/nu18071137
BibTeX
@article{Chabi2026,
author = {Chabi, Nicodème and Nominé-Criqui, Claire and Heinken, Almut and Quilliot, Didier and Brunaud, Laurent and Li, Zhen and Jeannesson-Thivisol, Elise and Sanni, Ambaliou and Ziegler, Olivier and Gueant, Jean-Louis and Guéant-Rodriguez, Rosa-Maria},
title = {Acylcarnitines Are Associated with Metabolic Syndrome and Hypertension in Two Contrasted Obese Populations},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {7},
pages = {1137},
doi = {10.3390/nu18071137}
}
EUVIMED